The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | Predicting SM/MGUS progression
Irene Ghobrial
• 12 Sep 2019
Irene Ghobrial, MD Dana-Farber Cancer Institute, Boston, MA discusses the need for a clearer understanding of which patients will progress from smoldering myeloma or MGUS to myeloma. Dr Ghobrial discusses how far we’ve come and the future outlook for these diseases at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
